Loading...
Xylem exceeded expectations in Q1 2025, posting growth in revenue and earnings, supported by healthy demand, operating discipline, and strategic pricing actions.
Revenue reached $2.1 billion, growing 2% year-over-year.
Reported EPS was $0.69; adjusted EPS was $1.03, up 14%.
Net income rose to $169 million, with an 8.2% net income margin.
First-quarter adjusted EBITDA margin expanded by 120 basis points to 20.4%.
Xylem reaffirmed its full-year 2025 guidance, expecting stable revenue growth and margin expansion despite market volatility.
Visualization of income flow from segment revenue to net income